PharmacoEconomics & Outcomes News

, Volume 807, Issue 1, pp 15–15 | Cite as

Funding two pneumococcal vaccines cost effective in Canada

Clinical study


  1. Atwood M, et al. Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults. Canadian Journal of Public Health. Revue Canadienne de Sante Publique : 9 May 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations